An Open Randomized Comparative clinical study of Malayufal modak(Yogratnakar)and Nagkeshar churna(Shodhal)in the management of Asrugdara with special reference to Menorrhagia
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Pictorial Blood loss assessment chart
研究概览
简要总结
Now a days due to unhealthy lifestyles, mental stress, Asrugdara disease increasing day by
day in reproductive age group female.Causes serious illness like general weakness, anemia
etc. In modern science, various therapeutic options given i.e., medical (Hormonal and/or
antifibrinolytics, anti-prostaglandins) and surgical (D & C, Endometrial ablation,
hysterectomy) but no treatment is free of side effects. In today’s world to maintain mental,
physical health of women,need to solve this emerging problem. So keeping all above ideas in
mind Malayufal modak is selected to evaluate and establish safe, cost effective, Ayurvedic
treatment in management of Asrugdara .Negligence in treatment causes anemia,
weakness/giddiness, mental confusion, delirium, drowsiness, dizziness, thirst, dysponea,
burning sensation,death.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 45.00 Year(s)（—）
- 性别
- Female
入选标准
- •Patients between age group of 18yrs to 45yrs
- •Patients having Haemoglobin more than 9gm%.
- •Patients mainly complaining of cardinal symptoms of Asrugdara (i.e. Ati rajastrava, atyadhik rajakalavadhi , Adhoudarshoola, Anaritukaal) for at least 2 consecutive cycles.
- •Patient ready to participate in study with proper written consent.
排除标准
- •Patients having malignant or benign tumour, fibroid, polyp, tubo ovarian mass, endometriosis, adenomyosis etc.
- •Patients having systemic diseases K/C/O.- Hypertension, Diabetes Mellitus, Endocrinal disorder.
- •Patients with IUCD or on OC pills or on Hormonal treatment.
- •Patients having gross abnormalities of uterus and pelvis.
- •Post-delivery, post MTP, post D & C bleeding.
- •Patient age below 18 year and above 45 year.
- •Bleeding disorders.
结局指标
主要结局
Pictorial Blood loss assessment chart
时间窗: 4 weeks
Hb(Before treatment)
时间窗: 4 weeks
USG Abdomen and Pelvis
时间窗: 4 weeks
BT CT (if necessary)
时间窗: 4 weeks
Thyroid Function Test (if necessary)
时间窗: 4 weeks
次要结局
- 1. Raja Atipravruthi(2. Deerghakalanubandhi)
研究者
Dr Rupali manohar Kamble
APMs Ayurved Mahavidyalaya Sion Mumbai